KLAS Contact
Contact KLAS
Contact KLAS
2026 BEST IN KLAS
Preferences
Related Series
Epic Bugsy 2026
Customer Recommendations for Organizations Considering Bugsy
Author
Jackson Tate
Author
Lance Merrell
Epic users in many areas of healthcare are optimistic about the vendor’s ability to deliver value and outcomes with their integrated ecosystem. However, this optimism is lacking among infection preventionists, who say the product’s development hasn’t improved sufficiently since it launched in 2015, and customer satisfaction with Bugsy is the lowest of any Epic inpatient solution measured by KLAS. Still, many healthcare organizations consider Bugsy in an effort to reduce costs and stay within the Epic environment. To help organizations who are considering Bugsy, this report examines the Bugsy customer experience, outlines the lift required for adoption, and compares the experience of Epic platform users who have chosen to retain their third-party infection prevention solutions rather than move to Bugsy. Also included are peer recommendations for organizations implementing Bugsy.
If you don't have a login, getting started is easy.
Key Findings:
- Most Infection Preventionists Feel Unheard & Undersupported by Epic
- Reporting Requires Significant Lift; Integration to Patient Chart Not Fully Ready Out of the Box
- Time & Strong Internal Support Are Often Required to Succeed with Bugsy; One-Third of Respondents Didn’t Reach a Successful State Within 12 Months
- Wolters Kluwer & VigiLanz See High Customer Satisfaction, Despite Integration Limitations
Writer
Sarah Brown
Designer
Nikki Christensen
Project Manager
Andrew Wright
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2026 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.